ClinicalTrials.gov
ClinicalTrials.gov Menu

Porous Tantalum Rods Improve the Hip Joint Function of Patients With Avascular Necrosis of the Femoral Head

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02877472
Recruitment Status : Recruiting
First Posted : August 24, 2016
Last Update Posted : August 24, 2016
Sponsor:
Information provided by (Responsible Party):
Heling Zhang, Qinghai University

Brief Summary:
To confirm 1) whether, compared with core decompression alone, core decompression with porous tantalum rod implantation improves the hip joint function of patients with avascular necrosis of the femoral head after femoral neck fracture surgery, 2) whether porous tantalum rod shows favorable biocompatibility with the human body, and 3) whether this treatment method is feasible for treating avascular necrosis of the femoral head after femoral neck fracture surgery.

Condition or disease Intervention/treatment Phase
Femoral Neck Fracture Device: porous tantalum rod Procedure: core decompression Not Applicable

Detailed Description:

History and current status of related studies: Femoral neck fracture can render the blood supply to the femoral head insufficient, leading to avascular necrosis of the femoral head. This often increases treatment difficulty and can have a strong influence on the recovery of hip joint function. Although core decompression for treatment of avascular necrosis of the femoral head has been largely used in clinical settings, the mid-term therapeutic effects are not satisfactory in some patients.

Biocompatibility is defined as the ability of a biomaterial, prosthesis, or medical device to perform with an appropriate host response. The biocompatibility of a bone implant and host influences the therapeutic effects. Therefore, biomaterials that are less likely to induce negative host responses may increase the therapeutic effects of such treatments for orthopedic diseases. A porous tantalum rod is a bone trabecula-like metal implant that is used to support weight-bearing areas of necrotic bone, preventing further collapse of the necrotic area. This implant has exhibited favorable effects in the early treatment of avascular necrosis of the femoral head. Although previous reports have focused on porous tantalum rod implantation for clinical treatment of avascular necrosis of the femoral head after fermoral neck fracture, few have assessed the long-term therapeutic effects or biocompatibility of porous tantalum rods.

Adverse events Possible adverse events include any expected or unexpected symptoms. If severe adverse events occur, information including the date of occurrence and measures taken related to the treatment of the adverse events will be reported to the principal investigator and the institutional review board within 24 hours.

Data collection, management, analysis, and open access Data collection: Case report forms with demographic data, disease diagnosis, accompanying diseases, drug allergy history, and adverse events will be collected , processed using Epidata software, collated, and then electrically recorded using a double-data entry strategy by data managers.

Data management: The locked electronic database will not be altered in any way, and will only be available to the project manager. Paper and electronic data regarding screening, informed consent, and clinical outcomes will be preserved at the Affiliated Hospital of Nantong University, China.

Data analysis: The electronic database will be made available to a professional statistician for statistical analysis. An outcome analysis report will be made by the statistician and submitted to the lead researchers. An independent data monitoring committee will supervise and manage the trial data with the goal of ensuring a scientific and stringent trial process, resulting in accurate and complete data.

Data open access: Anonymized trial data will be published at http://www.figshare.com.

Statistical analysis Statistical analysis will be performed by a statistician using SPSS 19.0 software and will follow the intention-to-treat principle. Normally distributed measurement data will be expressed as a mean, standard deviation, min, and max. Non-normally distributed measurement data will be expressed as a lower quartile (q1), median, and upper quartile (q3). McNemar's test will be used to compare the percentage of patients with excellent hip joint function as per Harris hip scores 12 months after surgery, the percentage of patients presenting with femoral head collapse, prosthesis loosening, peri-prosthesis infection, and incidence of complications 6 and 12 months after surgery. The Mann-Whitney U test will be used to compare the VAS score prior to and 1, 6, and 12 months after surgery. Statistical significance will be accepted when α = 0.05.


Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Porous Tantalum Rods Improve the Hip Joint Function of Patients With Avascular Necrosis of the Femoral Head After Femoral Neck Fracture Surgery: a Randomized Controlled Trial
Study Start Date : May 2015
Estimated Primary Completion Date : October 2016
Estimated Study Completion Date : May 2017

Resource links provided by the National Library of Medicine

Drug Information available for: Tantalum

Arm Intervention/treatment
Experimental: Experimental group
Patients with avascular necrosis of the femoral head after femoral neck fracture surgery will undergo core decompression and porous tantalum rod implantation (experimental group).
Device: porous tantalum rod
Patients with avascular necrosis of the femoral head after femoral head fracture surgery receive treatment of core decompression and porous tantalum rod implantation
Other Name: Experimental group

Experimental: Control group
Patients with avascular necrosis of the femoral head after femoral neck fracture surgery will undergo core decompression (control group).
Procedure: core decompression
Patients with avascular necrosis of the femoral head after femoral head fracture surgery will undergo core decompression.
Other Name: Control group




Primary Outcome Measures :
  1. Harris hip scores [ Time Frame: 12 months after surgery ]
    To evaluate the recovery of hip joint function. The Harris hip score ranges from 0-100 points with higher scores indicating better hip joint function. Hip joint function is scored as follows: ≥ 90 is excellent, 80-89 very good, 70-79 good, and < 70 poor.


Secondary Outcome Measures :
  1. Visual Analogue Scale (VAS) [ Time Frame: prior to and 1, 6, and 12 months after surgery ]
    To evaluate the severity of pain and ranges from 0-10, with higher scores indicating more severe pain.

  2. Incidences of complications [ Time Frame: 6 and 12 months after surgery ]
    To evaluate the safety of various implantation methods.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with fracture nonunion as indicated by a clear fracture line 12 months after femoral neck fracture; avascular necrosis of the femoral head as shown by cystic degeneration, sclerosis, and uneven density on X-ray images and CT scans
  • Patients with avascular necrosis of the femoral head after femoral neck fracture surgery who underwent internal fixation between 1 January 2016 and 31 May 2017
  • Age 18-80 years
  • Any sex and nationality
  • Provision of signed informed consent to participate in the trial

Exclusion Criteria:

  • Poor general health
  • Chronic disease or history of surgery
  • Alcohol abuse or long-term use of hormone drugs
  • Unable or declines to cooperate with treatment and examination because of language and/or mental disorders
  • Unable or declines to cooperate with rehabilitation treatment because of mental and/or psychological disorders

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02877472


Contacts
Contact: Heling Zhang, Master 8613997262938 helingzhang_qu@sina.com

Locations
China, Qinghai
Qinghai University Affiliated Hospital Recruiting
Xining, Qinghai, China, 810001
Contact: Heling Zhang, Master    8613997262938    helingzhang_qu@sina.com   
Sponsors and Collaborators
Qinghai University
Investigators
Principal Investigator: Heling Zhang, Master Affiliated Hospital of Qinghai University

Responsible Party: Heling Zhang, Attending Physician, Qinghai University
ClinicalTrials.gov Identifier: NCT02877472     History of Changes
Other Study ID Numbers: QinghaiUH_003
First Posted: August 24, 2016    Key Record Dates
Last Update Posted: August 24, 2016
Last Verified: August 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Additional relevant MeSH terms:
Osteonecrosis
Necrosis
Femoral Neck Fractures
Femur Head Necrosis
Pathologic Processes
Hip Fractures
Femoral Fractures
Fractures, Bone
Wounds and Injuries
Hip Injuries
Leg Injuries
Bone Diseases
Musculoskeletal Diseases